Modified biologically active proteins

Details Modified biologically active proteins Modified biologically active proteins

1990-07-02

1992-04-28

Moezie, F. T.

Drug, bio-affecting and body treating compositions

Lymphokine

530300, 530303, 530324, 530345, 530350, 5303911, 530409, 424 943, 514 2, 514 3, 514 12, 435177, C07K 1706, C12N 1100

Patent

active

051091186

ABSTRACT:
A modified biologically active protein consisting essentially of a biologically active protein bonded to lecithin via a covalent linking group and a pharmaceutical composition comprising the modified biologically active protein in a pharmaceutically-acceptable carrier. The biologically active proteins include antibodies, superoxide dismutase, insulin, and callidinogenase. Lecithin derivatives are also disclosed.

REFERENCES:
patent: 4957740 (1990-09-01), Wilder
Tan, Diss. Abstr. B, 27(12), pp. 4241-4242 (1967).
Alhaiq051081529 ue et al., J. Pharm. Pharmacol., Nov. 1975, 27(11), pp. 811-817 (abstract).

Affiliated with

Also associated with

Rating

Modified biologically active proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified biologically active proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified biologically active proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1250612